HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

OPEN ACCESS ARTICLE

This Article Free via Open Access: OA OA Full Text Full Text (PDF) OA All Versions of this Article: 2007-0057v1 25/8/1853    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Drummond, M. W. Articles by Brummendorf, T. H. Search for Related Content PubMed PubMed Citation Articles by Drummond, M. W. Articles by Brummendorf, T. H.

CANCER STEM CELLS

Concise Review: Telomere Biology in Normal and Leukemic Hematopoietic Stem Cells

^aDepartment of Haematology, Western Infirmary, Glasgow, United Kingdom;
^bDepartment of Oncology and Hematology, University Medical Center Eppendorf, Hamburg, Germany;
^cSection of Experimental Hematology, University of Glasgow, Glasgow, United Kingdom

Key Words. Telomere • Telomerase • Stem cell • Aging • Leukemia • Bone marrow failure

Correspondence: Mark W. Drummond, M.B., Ch.B., Ph.D., M.R.C.Path., Department of Haematology, Western Infirmary, Glasgow G11 6NT, U.K. Telephone: 0044-141-211-2156; Fax: 0044-141-211-6296; e-mail: Mark.drummond{at}northglasgow.scot.nhs.uk

Received January 22, 2007; accepted for publication April 9, 2007.
First published online in STEM CELLS EXPRESS   May 17, 2007.



The measurement of telomere length can give an insight into the replicative history of the cells in question. Much of the observed telomere loss occurs at the stem and progenitor cell level, even though these populations express the enzyme telomerase. Telomerase-transfected hematopoietic stem cells (HSC), although able to maintain telomere length, are still limited in terms of ability to undergo sequential transplantation, and other factors require to be addressed to achieve optimal levels of stem cell expansion. Unchecked telomere loss by HSC, meanwhile, would appear to play a significant role in the pathogenesis of bone marrow failure, as observed in the condition dyskeratosis congenita. This heterogeneous inherited condition appears to exhibit telomerase dysfunction as a common final pathogenic mechanism. Although less well-established for acquired marrow failure syndromes, mutations in key telomerase components have been described. The identification of the leukemic stem cell (LSC), along with the desire to target this population with anti-leukemia therapy, demands that telomerase biology be fully understood in this cell compartment. Future studies using primary selected LSC-rich samples are required. A better understanding of telomerase regulation in this population may allow effective targeting of the telomerase enzyme complex using small molecule inhibitors or additional novel approaches.

Disclosure of potential conflicts of interest is found at the end of this article.

This article has been cited by other articles:

				M. F. Haussmann and R. A. Mauck Telomeres and Longevity: Testing an Evolutionary Hypothesis Mol. Biol. Evol., January 1, 2008; 25(1): 220 - 228. [Abstract] [Full Text] [PDF]